PL3072515T3 - Farmaceutyczna kompozycja cytrynianu sildenafilu w postaci zawiesiny do podawania doustnego - Google Patents

Farmaceutyczna kompozycja cytrynianu sildenafilu w postaci zawiesiny do podawania doustnego

Info

Publication number
PL3072515T3
PL3072515T3 PL16380008T PL16380008T PL3072515T3 PL 3072515 T3 PL3072515 T3 PL 3072515T3 PL 16380008 T PL16380008 T PL 16380008T PL 16380008 T PL16380008 T PL 16380008T PL 3072515 T3 PL3072515 T3 PL 3072515T3
Authority
PL
Poland
Prior art keywords
suspension
pharmaceutical composition
oral use
sildenafil citrate
sildenafil
Prior art date
Application number
PL16380008T
Other languages
English (en)
Inventor
Fernando Martinez Alzamora
Antonia Gomez Calvo
Miguel RIZO MARTINEZ
Nuria SANZ MENEDEZ
Original Assignee
Farmalider, S.A.
Innovazone Labs LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmalider, S.A., Innovazone Labs LLC filed Critical Farmalider, S.A.
Publication of PL3072515T3 publication Critical patent/PL3072515T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
PL16380008T 2015-03-24 2016-03-15 Farmaceutyczna kompozycja cytrynianu sildenafilu w postaci zawiesiny do podawania doustnego PL3072515T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201500212A ES2584248B1 (es) 2015-03-24 2015-03-24 Composición farmacéutica de citrato de sildenafilo en forma de suspensión para uso oral
EP16380008.9A EP3072515B1 (en) 2015-03-24 2016-03-15 Pharmaceutical composition of sildenafil citrate in the form of a suspension for oral use

Publications (1)

Publication Number Publication Date
PL3072515T3 true PL3072515T3 (pl) 2018-12-31

Family

ID=55646513

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16380008T PL3072515T3 (pl) 2015-03-24 2016-03-15 Farmaceutyczna kompozycja cytrynianu sildenafilu w postaci zawiesiny do podawania doustnego

Country Status (11)

Country Link
US (1) US10016428B2 (pl)
EP (1) EP3072515B1 (pl)
AU (1) AU2017265087B2 (pl)
CY (1) CY1120282T1 (pl)
DK (1) DK3072515T3 (pl)
ES (2) ES2584248B1 (pl)
HR (1) HRP20180819T1 (pl)
HU (1) HUE037541T2 (pl)
MX (1) MX369760B (pl)
PL (1) PL3072515T3 (pl)
PT (1) PT3072515T (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3731870B1 (en) 2017-12-26 2025-11-12 Liqmeds Limited Liquid oral formulations for pde v inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5759579A (en) * 1996-12-05 1998-06-02 American Home Products Corporation Pharmaceutical suspension systems
US20070087981A1 (en) * 2002-02-08 2007-04-19 Lavipharm Laboratories, Inc. Water Soluble and Palatable Complexes
US20060024335A1 (en) * 2004-07-29 2006-02-02 Roger Stier E Oral compositions which mask the bitter taste of a bitter-tasting agent
US20090047330A1 (en) * 2007-08-17 2009-02-19 Ramesh Bangalore Oral fast dissolving films for erectile dysfunction bioactive agents
RU2488393C2 (ru) * 2007-11-12 2013-07-27 Новартис Аг Жидкие композиции, включающие валсартан
BR112013020237A2 (pt) * 2011-02-11 2021-03-16 Ctc Bio, Inc. Processo para preparar um filme contendo base livre de sildenafila e filme contendo base livre de sildenafila
ES2475942B1 (es) * 2013-01-11 2015-04-16 Farmalider, S.A. Composición farmacéutica de citrato de sildenafilo en forma de solución acuosa
MX2013001279A (es) * 2013-01-31 2013-08-26 Miguel Angel Garcia Perez Composicion farmaceutica con un inhibidor selectivo de la enzima fosfodiesterasa en forma de gel oral.

Also Published As

Publication number Publication date
AU2017265087B2 (en) 2018-11-01
HUE037541T2 (hu) 2018-09-28
MX2016003327A (es) 2017-01-05
PT3072515T (pt) 2018-05-25
AU2017265087A1 (en) 2018-01-04
US20160279133A1 (en) 2016-09-29
EP3072515A1 (en) 2016-09-28
EP3072515B1 (en) 2018-02-28
CY1120282T1 (el) 2019-07-10
ES2671543T3 (es) 2018-06-07
ES2584248B1 (es) 2017-04-19
DK3072515T3 (en) 2020-01-06
HRP20180819T1 (hr) 2018-07-13
ES2584248A1 (es) 2016-09-26
MX369760B (es) 2019-11-20
US10016428B2 (en) 2018-07-10

Similar Documents

Publication Publication Date Title
HUE058271T2 (hu) Tivozanibot tartalmazó gyógyászati készítmény
IL262058A (en) An oral preparation with unusual extraction capacity
ZA201601656B (en) Inhalable pharmaceutical composition
ZA201703562B (en) Pharmaceutical composition for oral administration comprising taxane
ZA201902622B (en) Oral care composition
ZA201902623B (en) Oral care composition
PL3318259T3 (pl) Stabilna kompozycja farmaceutyczna do podawania doustnego
SI3157506T1 (sl) Oralni farmacevtski sestavek z zamaskiranim okusom
PL3313370T3 (pl) Okulistyczna kompozycja farmaceutyczna
GB201615917D0 (en) Pharmaceutical composition
SG11201505385VA (en) Pharmaceutical composition in the form of a tabletand a method for producing same
SG11201710708VA (en) Oral composition
GB201615914D0 (en) Pharmaceutical composition
SG11201708597VA (en) Oral care composition
PL3250188T3 (pl) Kompozycja farmaceutyczna zawierająca Aprepitant oraz sposób jej wytwarzania
EP3156038A4 (en) Composition for use in oral cavity
ZA201903378B (en) Oral care composition
HRP20180819T1 (hr) Farmaceutski pripravak sildenafil-citrata u obliku suspenzije namijenjene oralnoj upotrebi
GB201615910D0 (en) Pharmaceutical composition
EP3162368A4 (en) Pharmaceutical composition for oral administration
HUP1600415A2 (en) Pimavanserin salts for the manufacture of pharmaceutical formulations
PL3169311T3 (pl) Proszek do stosowania u dzieci do sporządzania zawiesiny doustnej zawierający środek przeciwwirusowy i sposób jego wytwarzania
GB201611767D0 (en) Oral particulate composition
PL3409261T3 (pl) Dentystyczna masa odlewnicza
ZA201509174B (en) An oral medicinal composition